Skip to main content

Table 1 Demographic and clinical characteristics of MS patients in relapse and remission

From: Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis

Characteristic

MS relapse

MS remission

Age (years, mean ± SD)

34.5 ± 9.4

36.9 ± 5.2

Women:men (n:n)

16:4

10:7

Onset age (years, mean ± SD)

30.4 ± 22.0

29.8 ± 7.3

Disease duration (years, mean ± SD)

12 ± 24.9

6 ± 5.9

EDSS (mean ± SD)

2.9 ± 1.9

1.8 ± 1.9